Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.1186/1471-2164-9-171

Título: Transcriptional regulation by poly(ADP-ribose) polymerase-1 during T cell activation
Fecha de publicación: 16-abr-2008
Editorial: BMC
Cita bibliográfica: BMC Genomics 9, 2008:171
ISSN: Electronic: 1471-2164
Resumen: Background: Accumulating evidence suggests an important role for the enzyme poly(ADPribose) polymerase-1 (PARP-1) as an integral part of the gene expression regulatory machinery during development and in response to specific cellular signals. PARP-1 might modulate gene expression through its catalytic activity leading to poly(ADP-ribosyl)ation of nuclear proteins or by its physical association with relevant proteins. Recently, we have shown that PARP-1 is activated during T cell activation. However, the proposed role of PARP-1 in reprogramming T cell gene expression upon activation remains largely unexplored. Results: In the present study we use oligonucleotide microarray analysis to gain more insight into the role played by PARP-1 during the gene expression reprogramming that takes place in T cells upon activation with anti-CD3 stimulation alone, or in combination with anti-CD28 co-stimulation. We have identified several groups of genes with expression modulated by PARP-1. The expression of 129 early-response genes to anti-CD3 seems to be regulated by PARP-1 either in a positive (45 genes) or in a negative manner (84 genes). Likewise, in the presence of co-stimulation (anti-CD3 + anti-CD28 stimulation), the expression of 203 genes is also regulated by PARP-1 either up (173 genes) or down (30 genes). Interestingly, PARP-1 deficiency significantly alters expression of genes associated with the immune response such as chemokines and genes involved in the Th1/Th2 balance. Conclusion: This study provides new insights into changes in gene expression mediated by PARP1 upon T cell activation. Pathway analysis of PARP-1 as a nuclear signalling molecule in T cells would be of relevance for the future development of new therapeutic approaches targeting PARP-1 in the acquired immune response.
Autor/es principal/es: Valdor, Rut
Saenz, Luis
Lozano, Juan J
Baroja Mazo, , Alberto
Ramirez, Pablo
Parrilla, Pascual
Aparicio, Pedro
Sumoy, Lauro
Yélamos, José
Facultad/Departamentos/Servicios: Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Bioquímica y Biología Molecular "B" e Inmunología
Versión del editor: https://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-9-171
URI: http://hdl.handle.net/10201/138857
DOI: https://doi.org/10.1186/1471-2164-9-171
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 11
Derechos: info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Descripción: ©2008. This manuscript version is made available under the CC-BY4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Published, version of a Published Work that appeared in final form in BMC Genomics. To access the final edited and published work see https://doi.org/10.1186/1471-2164-9-171
Aparece en las colecciones:Artículos: Bioquímica y Biología Molecular "B" e Inmunología

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
BMC genomics.pdf535,57 kBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons